Efficacy and side effects estimation of 5% dapsone gel in the treatment of mild to moderate acne vulgaris
DOI:
https://doi.org/10.66344/jpad.v33i4.2475Keywords:
acne vulgaris, 5% Dapsone gelAbstract
Background Acne vulgaris is a common dermatosis characterized by inflammation of the pilosebaceous unit, and clinically manifests as comedones, papules, pustules, nodules or cystic lesions. These may either present alone or in combination and affect predominantly the face and upper trunk. 5% dapsone gel has been approved to treat acne vulgaris.
Methods An interventional study was conducted during a 6 month period in the Dermatology Outpatient Department of Akhtar Saeed Medical and Dental College, Lahore. All patients fulfilling the inclusion criteria were enrolled and were advised to 5% dapsone gel twice daily on their face for 3 months. They were followed up at weeks 2, 4, 8 and 12. Response to treatment was evaluated using the Investigator Global Acne Severity Assessment Scale (IGA). Drug efficacy was also evaluated by calculating mean percent reduction of lesions. Side effects estimation like burning, stinging, erythema and dryness was noted.
Results At the end of 12 weeks, 5% dapsone gel was found to be effective in reducing both inflammatory and noninflammatory lesions by 59.2% and 40.8% respectively. The drug was also tolerable and had minimal side effects.
Conclusion 5% dapsone gel was well tolerated and efficacious in the treatment of mild to moderate acne vulgaris.
References
1. Jawade SA, Singh A. Efficacy of Dapsone 5% gel in treatment of acne vulgaris. International journal of research in dermatology. Oct 2016;2 (4). 77-83.
2. Alanazi , M.S , Hammad, S.M, Mohammad A.E. prevalence and psychological impact of acne vulgaris among female secondary school students in Arar city ,Saudi Arabia. Electronic physician, 2018; 10(8) .7224-7229, http://doi.org/10.19082/7224.
3. Babar O, Mobeen A. prevalence and psychological impact of acne vulgaris in female undergraduate medical students of Rawalpindi and Islamabad, Pakistan. cureus. sep 2019; 11(9).
4. Bhat YJ. Latief I, Hassan I. update on etiopathogenesis and treatment of acne. Indian Journal of Dermatology, venereology and leprosy 2017; 83: 298-306.
5. Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. the journal of dermatological treatment , 2021; 32(3), 277-285.
6. Kircik, Leon H. Advances in the understanding of the pathogenesis of inflammatory acne. Journal of drugs in dermatology: SDD vol, 15. Suppl 1 (2016): s7-10.
7. Conzalez –Mondragen, Edgar A et al. acne and diet: a review of pathogenic mechanisms. Boletin medico del hospital infantile de mexico. Vol 79, 2 (2022) : 83-90.
8. Stotland M, Shalia Atan R, Kissling Robert F. Dapsone 5% gel, a review of its efficacy and safety in the treatment og acne vulgaris, Am j clin dermatol 2009; 10(4) :221-227.
9. Kirick L. Harnessing. The anti inflammatory effects of topical dapsone for management of acne. J. Drugs Dermatol. 2010: 9(6): 667-71.
10. Kosmadaki M, Katisambas A. Topical treatments for acne. Clinics in dermatology. 2017 March 1 ; 35(2) :173-8.
11. Neritia Hazarika, M. Archana. The psychological impact of Acne vulgaris. Indian J Dermatol.sep- oct (2016);61(5): 515-520.
12. Kurokawa, Ichiro, Keisuke Nakase. Recent advances in understanding and managing acne. F 1000 Research vol 9. F 1000 Faculty Rev- 792, 29 Jul. 2020.
13. Ghaoui, Nohra et al. update on the use of dapsone in dermatology. International journal of dermatology vol.59, 7 (2020): 787-795.
14. Khalilzaedah, Mina et al. A comprehensive insight into the anti inflammatory properties of dapsone. Naunyn-Schmideeberg’s archives of pharmacology vol.395, 12 (2022): 1509-1523.
15. Xuesong Wang, Zhenzhen Wang et al. Efficacy and safety of dapsone gel for acne: a systematic review and meta analysis. Annals of Palliative medicine vol 11, No.2 (2022).
16. Nickles, M.A, Lake E. Topical dapsone in the treatment of acne: a systemic review. Int J. Dermatol, 61: 2022. 1412-1421.
17. Tan J. Dapsone 5% gel: a new option in topical therapy for acne. skin therapy letter vol.17, 18 (2012): 1-3.
18. Alexis, Andrew F.et al. The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult felames with skin colour. Journal of Drugs in Dermatology: JDD.15 (2): 2016: 197-204.
19. Tanghetti, Emil.et al. clinical evidence for the role of topical anti inflammatory agent in comedonal acne, findings from a randomized study of dapsone gel 5% in combination with tazoretene cream 0.1% in patients with acne vulgaris. Journal of drugs in dermatology: JDD .10(7) (2011): 783-792.
20. Lynde CW. Andriessen A. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women. Skin med. Jan-feb 2014; 12 (1): 15-21.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Rabia Anjum, Rabail Majeed, Nauman Dawood, Sabahat Shahzadi, Fatima Sheikh, Mariam Sheikh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
